📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Qumas

1.1 - Company Overview

Qumas Logo

Qumas

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a closed-loop compliance model that standardizes and integrates common elements of compliance tasks across the organization, enabling enterprises to converge compliance programs onto a single platform to reduce compliance costs and create competitive advantage.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Qumas

Nucleai Logo

Nucleai

HQ: United States Website
  • Description: Provider of an AI-powered spatial biology platform designed to enhance drug development and improve patient outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nucleai company profile →
ClearTrial Logo

ClearTrial

HQ: United States Website
  • Description: Provider of cloud-based clinical trial operations software (SaaS) enabling biopharmaceutical and medical device manufacturers to plan, outsource, and track clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ClearTrial company profile →
EncrypGen Logo

EncrypGen

HQ: United States Website
  • Description: Provider of next-generation software for genomic data, empowering patients and donors and facilitating health, business, and science.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EncrypGen company profile →
MDDX Logo

MDDX

HQ: United States Website
  • Description: Provider of technologies and affordable research applications that unlock insights your data did not reveal, improving efficiency and scalability of multicenter trials; offering nearly a dozen tools used by thousands of researchers in dozens of global research trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MDDX company profile →
Vividion Therapeutics Logo

Vividion Therapeutics

HQ: United States Website
  • Description: Provider of a proteome-wide chemoproteomic platform for drug and target discovery and small-molecule therapeutics in oncology and immunology, including programs for NRF2 inhibition in squamous lung, head, neck and esophageal cancers; NRF2 activation for inflammation-induced tissue injury; STAT3 targeting (incl. oral investigational VVD-130850 for advanced solid and hematologic tumors); and Werner helicase targeting for microsatellite instability cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vividion Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Qumas

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Qumas

2.2 - Growth funds investing in similar companies to Qumas

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Qumas

4.2 - Public trading comparable groups for Qumas

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Qumas

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Qumas

What does Qumas do?

Qumas is a provider of a closed-loop compliance model that standardizes and integrates common elements of compliance tasks across the organization, enabling enterprises to converge compliance programs onto a single platform to reduce compliance costs and create competitive advantage.

Who are Qumas's competitors?

Qumas's competitors and similar companies include Nucleai, ClearTrial, EncrypGen, MDDX, and Vividion Therapeutics.

Where is Qumas headquartered?

Qumas is headquartered in United States.

How many employees does Qumas have?

Qumas has 1,000 employees 🔒.

When was Qumas founded?

Qumas was founded in 2010 🔒.

What sector and industry vertical is Qumas in?

Qumas is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Qumas

Who are the top strategic acquirers in Qumas's sector and industry

Top strategic M&A buyers and acquirers in Qumas's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Qumas?

Top strategic M&A buyers groups and sectors for Qumas include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Qumas's sector and industry vertical

Which are the top PE firms investing in Qumas's sector and industry vertical?

Top PE firms investing in Qumas's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Qumas's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Qumas's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Qumas's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Qumas include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Qumas's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Qumas?

The key public trading comparables and valuation benchmarks for Qumas include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Qumas for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Qumas with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Qumas's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Qumas with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Qumas's' sector and industry vertical?

Access recent funding rounds and capital raises in Qumas's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Qumas